The plant genomics market is estimated to account for a value of USD 7.3 billion in 2019 and is projected to grow at a CAGR of 8.3% from 2019, to reach a value of USD 11.7 billion by 2025. The increasing application of genomics in plant breeding and conservation of genetic resources are techniques that are gaining the attention of many researchers globally and are driving the growth of the market.
The molecular engineering segment is estimated to witness the fastest growth in the plant genomics market, in terms of value, from 2019 to 2025
Molecular engineering is the process of improving the genotypic characteristics of plants through the application of molecular markers. Plant molecular engineering is the process of modification of plant material or plants for the production of novel compounds or to improve the efficiency of beneficial products. The benefits associated with molecular engineering technologies are the major factors contributing to the fastest growth of this market, globally.
Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=239362357
The demand for healthy cereals & grains has created opportunities for seed manufacturers to adopt modern plant sequencing techniques
The growth in the adoption of various molecular breeding types, such as molecular engineering and genetic engineering tools, would increase the performance of crops to gain better prices in the market. The focus of the plant breeders and plant sequencing companies is on cereals and grains because they are the staple diet of the population in almost all the regions, and as the population of the world is increasing, so is the demand for the staple food. Among cereals & grains, rice, wheat, and corn are majorly bred using plant breeding & sequencing techniques, to develop high-performing varieties. Rice, along with wheat and corn, underpins the global food supply.
The increasing demand for improved varieties in plants in the Asia Pacific region is driving the growth of the plant genomics market.
The key players in various countries of the Asia Pacific region are focusing on directing their investments toward biotechnology research on food crops and crops of high commercial value to cater to the increasing food requirements and to reduce poverty, particularly among resource-poor farming households. With the adoption of modern plant breeding techniques, new crop cultivars can be developed to ensure high crop productivity. Also, key strategies such as the adoption of advanced plant technology by the leading players in the Asia Pacific region ensure food security globally among the end-users. Also, the government in various countries of the region are encouraging companies to adopt these methods by investing in R&D of agricultural biotechnology.
This report includes a study on the marketing and development strategies, along with a study on the product portfolios of the leading companies operating in the plant genomics market. It includes the profiles of leading companies such as Eurofins Scientific (Luxembourg), Illumina, Inc. (US), NRGene (Israel), Neogen Corporation (US), Qiagen (Germany), Agilent Technologies (US), KeyGene (Netherlands), LC Sciences (US), Traitgenetics GmbH (Germany), Novogene Corporation (China), Oxford Nanopore Technologies (UK), Genewiz (US), BGI Genomics (China), Genotypic Technologies (India), and Floragenex (US).
Make an Inquiry: https://www.marketsandmarkets.com/Enquiry_Before_BuyingNew.asp?id=239362357
Key questions addressed by the report:
• What are the new application areas that the companies are exploring for the market?
• Who are some of the key players operating in the market and how intense is the competition?
• What kind of competitors and stakeholders would be interested in this market? What will be their go-to-market strategy, and which emerging market will be of significant interest?
• How are the current R&D activities and M&A’s in the plant genomics market projected to create a disrupting environment in the coming years?
• What will be the level of impact of new product launches on the revenues of stakeholders, due to the benefits offered by plant genomics, in terms of revenue growth, environmental regulatory compliance, and sustainable profits for the suppliers?